The integration ofcannabinoidsinto mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade.
Today, there is a growing list of market-authorized drugs containing cannabinoids.
Similarly, Sativex, which contains both THC and CBD, is prescribed for spasticity due to multiple sclerosis.
However, the market still feels fragmented, as these products primarily focus on specific medical conditions.
The complexities involved in cannabinoid pharmacology pose challenges for researchers and developers.
Cannabinoids interact with the endocannabinoid system in intricate ways, influencing a variety of physiological processes.
This complexity requires extensive research to establish effective dosages, safety profiles and therapeutic indications for various cannabinoids.
The Rolling Stone Culture Councilis an invitation-only community for Influencers, Innovators and Creatives.Do I qualify?
As more patients seek alternatives to traditional pharmaceuticals, the demand for cannabinoid-based therapies is expected to rise significantly.
Investors are taking notice, recognizing the lucrative opportunities presented by the cannabinoid market.
